Animal models of Parkinson’s disease and L-dopa induced dyskinesia: How close are we to the clinic?

被引：0
|
作者：
Emma Lane
Stephen Dunnett
机构：
[1] Cardiff University,School of Bioscience
来源：
Psychopharmacology | 2008年 / 199卷
关键词：
Parkinson’s disease; L-dopa-induced dyskinesia; 6-OHDA lesioned rat; MPTP-treated primate; Animal models;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：303 / 312
页数：9
相关论文
共 50 条
  • [41] Cell replacement therapy for Parkinson's disease: how close are we to the clinic?
    Ganz, Javier
    Lev, Nirit
    Melamed, Eldad
    Offen, Daniel
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (09) : 1325 - 1339
  • [42] An Integrative Approach to Treat Parkinson's Disease: Ukgansan Complements L-Dopa by Ameliorating Dopaminergic Neuronal Damage and L-Dopa-Induced Dyskinesia in Mice
    Huh, Eugene
    Choi, Din Gyu
    Sim, Yeomoon
    Oh, Myung Sook
    FRONTIERS IN AGING NEUROSCIENCE, 2019, 10
  • [43] Analysis of structural plastic changes underlying L-DOPA induced dyskinesias in an animal model of Parkinson's disease
    Taravini, I.
    Suarez, L. M.
    Gomez, G.
    Larramendy, C.
    Saborido, M.
    Escande, M.
    Belforte, J.
    Rela, L.
    Moratalla, R.
    Murer, G.
    Gershanik, O.
    JOURNAL OF NEUROCHEMISTRY, 2012, 122 : 29 - 29
  • [44] Onset age or age for initial L-dopa treatment: Which is a more important risk factor for L-DOPA-induced dyskinesia in Parkinson's disease?
    Kimura, T.
    Tomiyama, M.
    Arai, A.
    Suzuki, C.
    Kawarabayashi, T.
    Shoji, M.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S118 - S118
  • [45] Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease
    Visanji, Naomi P.
    Fox, Susan H.
    Johnston, Tom
    Reyes, Gabriela
    Milian, Mark J.
    Brotchie, Jonathan M.
    NEUROBIOLOGY OF DISEASE, 2009, 35 (02) : 184 - 192
  • [46] Modeling sleep alterations in Parkinson's disease: How close are we to valid translational animal models?
    Fifel, Karim
    Piggins, Hugh
    Deboer, Tom
    SLEEP MEDICINE REVIEWS, 2016, 25 : 95 - 111
  • [47] How reliable is the behavioural evaluation of dyskinesia in animal models of Parkinson's disease?
    Carta, Anna R.
    Pinna, Annalisa
    Morelli, Micaela
    BEHAVIOURAL PHARMACOLOGY, 2006, 17 (5-6): : 393 - 402
  • [48] μ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease
    Bezard, Erwan
    Li, Qin
    Hulme, Heather
    Fridjonsdottir, Elva
    Nilsson, Anna
    Pioli, Elsa
    Andren, Per E.
    Crossman, Alan R.
    JOURNAL OF NEUROSCIENCE, 2020, 40 (35): : 6812 - 6819
  • [49] L-dopa-induced dyskinesia in Parkinson's disease: The French dopamip survey
    Rascol, O.
    Negre-Pages, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 205 - 205
  • [50] Abnormal cortical facilitation and L-dopa-induced dyskinesia in Parkinson's disease
    Guerra, Andrea
    Suppa, Antonio
    D'Onofrio, Valentina
    Di Stasio, Flavio
    Asci, Francesco
    Fabbrini, Giovanni
    Berardelli, Alfredo
    BRAIN STIMULATION, 2019, 12 (06) : 1517 - 1525
12345